Aurora Cannabis Elevates Polish Medical Market with Record Potency
EDMONTON, AB / NEW YORK, NY – [Insert Date Here, e.g., July 25, 2024] – Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a leading Canadian medical cannabis company, has significantly expanded its footprint and product offering in the Polish market with the introduction of two proprietary high-potency dried flower cultivars: Farm Gas and Sourdough. These new products establish a new benchmark for Tetrahydrocannabinol (THC) content, representing the highest potency medical cannabis currently available for prescription in Poland.
The strategic launch addresses growing demand from healthcare professionals and patients for diverse and potent treatment options within the regulated medical cannabis framework in the country. The introduction of these cultivars follows their successful reception and clinical use in the Canadian medical cannabis market.
Details of the New Cultivars
The two new high-THC cultivars offer distinct genetic profiles and characteristics aimed at providing prescribers and patients with greater choice.
Farm Gas, with a notable THC concentration of 27% and less than 1% Cannabidiol (CBD), became available for prescription in Poland starting June 30, 2025. This cultivar is bred from the genetics of Sour Diesel and GMO strains, known for their potent effects and complex aromas. Its terpene profile is characterized by the presence of limonene and caryophyllene, contributing to aroma notes described as kerosene, diesel, and gas.
Following closely, Sourdough boasts an even higher THC level of 29%, also with less than 1% CBD. This cultivar is slated for availability in early August 2025. Sourdough is derived from the genetics of Cake and Diesel strains. Its terpene profile includes limonene, caryophyllene, and myrcene, which impart distinct aroma notes of sour, cake, and gasoline.
Both Farm Gas and Sourdough are offered as dried medical cannabis flower products.
Cultivation, Manufacturing, and Quality Standards
A cornerstone of Aurora’s market strategy is the commitment to producing high-quality, consistent medical cannabis products. Both the Farm Gas and Sourdough cultivars cultivated for the Polish market are grown and manufactured at Aurora’s state-of-the-art facilities in Canada.
Crucially, these facilities operate under strict quality control standards, holding both GACP (Good Agricultural and Collection Practice) and EU-GMP (European Union Good Manufacturing Practice) certifications. Adherence to GACP ensures that the cultivation processes meet rigorous standards for quality and consistency from seed to harvest. The EU-GMP certification is particularly significant for the European market, demonstrating that the manufacturing processes comply with the highest pharmaceutical-grade quality standards required for medical products distributed within the European Union. This dual certification provides assurance to Polish prescribers and patients regarding the safety, quality, and reliability of Aurora’s medical cannabis products.
Meeting Market Demand
The decision to introduce these specific high-potency cultivars into the Polish market was driven by observed success in other medical markets, particularly Canada, and a clear signal from healthcare practitioners in Poland.
Michael Simon, VP of Commercial at Aurora Europe, highlighted the strategic thinking behind the launch. “These cultivars are being introduced based on their success in the Canadian market to meet prescriber demand for high-quality, high-potency products,” stated Mr. Simon. His comments underscore Aurora’s responsiveness to the evolving needs of the Polish medical community and its commitment to leveraging its extensive genetic bank and cultivation expertise to provide tailored solutions.
The availability of higher THC options is often sought by prescribers for patients with specific medical conditions where higher cannabinoid concentrations may be deemed appropriate as part of a comprehensive treatment plan. By introducing products at the 27% and 29% THC levels, Aurora is directly addressing this clinical demand and expanding the therapeutic toolkit available to Polish doctors.
Outlook for the Polish Medical Cannabis Market
The launch of Farm Gas and Sourdough is anticipated to have a significant impact on the Polish medical cannabis landscape. By setting a new standard for potency and offering carefully characterized cultivars with detailed genetic and terpene profiles, Aurora is contributing to the maturation of the market.
This development provides patients in Poland with access to medical cannabis products comparable in quality and potency to those available in more established markets like Canada and Germany. It also signifies the increasing acceptance and integration of medical cannabis into the healthcare system, with a focus on providing diverse and effective treatment options based on physician assessment and patient needs.
As the Polish medical cannabis market continues to grow and evolve, the introduction of high-quality, high-potency products cultivated under stringent international standards is a key step towards ensuring patients have access to a wide range of reliable medical options. Aurora’s latest launch positions the company as a key supplier in this expanding market, committed to quality and responding to the specific requirements of prescribers and patients.
